Evidence map›Paper›PMID 41011235›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Modified Liuwei Dihuang Decoction Ameliorates Oligoasthenozoospermia in Mice via Modulation of the PI3K/AKT/Nrf2 Signaling Pathway.

Mingzhu Li, Linhuang Chen, Haotian Xu, Junlin Li, Yatian Liu, Xiuyun Chen, Minyi Luo, Xinyuan Xie, Mingyu Yin, Jinyang He

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mingzhu LiScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Linhuang ChenScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Haotian XuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Junlin LiScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Yatian LiuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Xiuyun ChenScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Minyi LuoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Xinyuan XieArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Mingyu YinScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Jinyang HeScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID 0000-0002-2485-1585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

inflammationModified Liuwei Dihuang DecoctionOligoasthenozoospermiaoxidative stressPI3K/AKT/Nrf2 signaling pathway

Identifiers

PMID41011235
PMCPMC12472625

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.